Andrew Berchuck, MD
Professor
Duke University Medical Center
Dept. of OB/GYN
Box 3079 DUMC
Durham,
NC
USA
27710
Biographical Sketch: Dr Berchuck has 25 years experience in translational ovarian cancer molecular research and is the head of the steering committee of the ovarian cancer association consortium, which performed this research. Dr. Berchuck is director of the Duke University Division of Gynecologic Oncology."
Papers:
60
KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)
144
Relationship between Body Mass Index (BMI) and gene expression profiles of high grade serous ovarian cancers in The Cancer Genome Atlas (TCGA) project
226
Sentinel lymph node mapping in women with high risk histology endometrial cancer
273
Findings at laparoscopy, not debulking status, are associated with survival in advanced stage ovarian cancer after neoadjuvant chemotherapy
428
New cases of small cell carcinoma of the ovary, hypercalemic type caused by germline SMARCA4 mutations: an under-diagnosed entity?
508
Evaluation of ERRα expression and association with survival in advanced ovarian cancer
The birth of the SGO wellness taskforce